Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02823405
Brief Title: X4P-001 and Pembrolizumab in Patients With Advanced Melanoma (X4P-001-MELA)

First Submitted : July 1, 2016
First Submitted that Met QC Criteria : July 1, 2016
First Posted : July 6, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 1, 2020
Last Update Posted : July 7, 2020